切换至 "中华医学电子期刊资源库"

中华医学超声杂志(电子版) ›› 2022, Vol. 19 ›› Issue (01) : 78 -81. doi: 10.3877/cma.j.issn.1672-6448.2022.01.015

综述

甲状腺微小乳头状癌射频消融治疗的临床价值与展望
张明博1, 阎琳1, 李盈盈1, 罗渝昆1,()   
  1. 1. 100853 北京,解放军总医院第一医学中心超声诊断科
  • 收稿日期:2020-09-09 出版日期:2022-01-01
  • 通信作者: 罗渝昆

Radiofrequency ablation of papillary thyroid microcarcinoma: clinical value and prospects

Mingbo Zhang1, Lin Yan1, Yingying Li1   

  • Received:2020-09-09 Published:2022-01-01
引用本文:

张明博, 阎琳, 李盈盈, 罗渝昆. 甲状腺微小乳头状癌射频消融治疗的临床价值与展望[J]. 中华医学超声杂志(电子版), 2022, 19(01): 78-81.

Mingbo Zhang, Lin Yan, Yingying Li. Radiofrequency ablation of papillary thyroid microcarcinoma: clinical value and prospects[J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2022, 19(01): 78-81.

表1 PTMC射频消融治疗的文献总结
1
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016 [J]. CA Cancer J Clin, 2016, 66(1): 7-30.
2
赵平, 陈万青. 2010中国肿瘤登记年报 [M]. 北京: 军事医学科学出版社, 2010: 74-75.
3
Lloyd RV, Buehler D, Khanafshar E. Papillary thyroid carcinoma variants [J]. Head Neck Pathol, 2011, 5(1): 51-56.
4
Roti E, Degli Uberti EC, Bondanelli M, et al. Thyroid papillary microcarcinoma: a descriptive and meta-analysis study [J]. Eur J Endocrinol, 2008, 159(6): 659-673.
5
Ito Y, Miyauchi A, Kihara M, et al. Patient age is significantly related to the progression of papillary microcarcinoma of the thyroid under observation [J]. Thyroid, 2014, 24(1): 27-34.
6
Sugitani I, Toda K, Yamada K, et al. Three distinctly different kinds of papillary thyroid microcarcinoma should be recognized: our treatment strategies and outcomes [J]. World J Surg, 2010, 34(6): 1222-1231.
7
Lang BH, Wong CKH. Lobectomy is a more cost-effective option than total thyroidectomy for 1 to 4 cm papillary thyroid carcinoma that do not possess clinically recognizable high-risk features [J]. Ann Surg Oncol, 2016, 23(11): 3641-3652.
8
Sethukumar P, Ly D, Awad Z, et al. Scar satisfaction and body image in thyroidectomy patients: prospective study in a tertiary referral centre [J]. J Laryngol Otol, 2018, 132(1): 60-67.
9
Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer [J]. Thyroid, 2016, 26(1): 1-133.
10
Cho SJ, Suh CH, Baek JH, et al. Active surveillance for small papillary thyroid cancer: a systematic review and meta-analysis [J]. Thyroid, 2019, 29(10): 1399-1408.
11
Lee GM, You JY, Kim HY, et al. Successful radiofrequency ablation strategies for benign thyroid nodules [J]. Endocrine, 2019, 64(2): 316-321.
12
Baek JH, Kim YS, Sung JY, et al. Locoregional control of metastatic well-differentiated thyroid cancer by ultrasound-guided radiofrequency ablation [J]. AJR Am J Roentgenol, 2011, 197(2): W331-W336.
13
Park KW, Shin JH, Han BK, et al. Inoperable symptomatic recurrent thyroid cancers: preliminary result of radiofrequency ablation [J]. Ann Surg Oncol, 2011, 18(9): 2564-2568.
14
Guang Y, Luo Y, Zhang Y, et al. Efficacy and safety of percutaneous ultrasound guided radiofrequency ablation for treating cervical metastatic lymph nodes from papillary thyroid carcinoma [J]. J Cancer Res Clin Oncol, 2017, 143(8): 1555-1562.
15
中国医师协会超声医师分会. 甲状腺微小乳头状癌热消融诊疗指征专家共识 [J/CD]. 中华医学超声杂志(电子版), 2019, 16(8): 571-574.
16
Zhang M, Tufano RP, Russell J, et al. Ultrasound-guided radiofrequency ablation versus surgery for low-risk papillary thyroid microcarcinoma: results of over 5 years' follow-up [J]. Thyroid, 2020, 30(3): 408-417.
17
Cho SJ, Baek SM, Lim HK, et al. Long-term follow-up results of ultrasound-guided radiofrequency ablation for low-risk papillary thyroid microcarcinoma: more than 5-year follow-up for 84 tumors [J]. Thyroid, 2020, 30(12): 1745-1751.
18
Lim HK, Cho SJ, Baek JH, et al. US-guided radiofrequency ablation for low-risk papillary thyroid microcarcinoma: efficacy and safety in a large population [J]. Korean J Radiol, 2019, 20(12): 1653-1661.
19
Kim JH, Baek JH, Sung JY, et al Radiofrequency ablation of low-risk small papillary thyroidcarcinoma: preliminary results for patients ineligible for surgery [J]. Int J Hyperthermia, 2017, 33(2): 212-219.
20
Xiao J, Zhang M, Zhang Y, et al. Efficacy and safety of ultrasonography-guided radiofrequency ablation for the treatment of T1bN0M0 papillary thyroid carcinoma: a retrospective study [J]. Int J Hyperthermia, 2020, 37(1): 392-398.
21
Rhim H, Goldberg SN, Dodd GD, et al. Essential techniques for successful radio-frequency thermal ablation of malignant hepatic tumors [J]. Radiographics, 2001, 21: S17-S39.
22
Shin JH, Baek JH, Ha EJ, et al. Radiofrequency ablation of thyroid nodules: basic principles and clinical application [J]. Int J Endocrinol, 2012, 2012: 919650.
23
Park HS, Baek JH, Park AW, et al. Thyroid radiofrequency ablation: updates on innovative devices and techniques [J]. Korean J Radiol, 2017, 18(4): 615-623.
24
Jeong WK, Baek JH, Rhim H, et al. Radiofrequency ablation of benign thyroid nodules: safety and imaging follow-up in 236 patients [J]. Eur Radiol, 2008, 18(6): 1244-1250.
25
Zhang M, Luo Y, Zhang Y, et al. Efficacy and safety of ultrasound-guided radiofrequency ablation for treating low-risk papillary thyroid microcarcinoma: a prospective study [J]. Thyroid, 2016, 26(11): 1581-1587.
26
Ding M, Tang X, Cui D, et al. Clinical outcomes of ultrasound-guided radiofrequency ablation for the treatment of primary papillary thyroid microcarcinoma [J]. Clin Radiol, 2019, 74(9): 712-717.
27
Zhang Y, Zhang MB, Luo YK, et al. Effect of chronic lymphocytic thyroiditis on the efficacy and safety of ultrasound-guided radiofrequency ablation for papillary thyroid microcarcinoma [J]. Cancer Med, 2019, 8(12): 5450-5458.
28
Wu R, Luo Y, Tang J, et al. Ultrasound-guided radiofrequency ablation for papillary thyroid microcarcinoma: a retrospective analysis of 198 patients [J]. Int J Hyperthermia, 2020, 37(1): 168-174.
29
Choi Y, Jung SL. Efficacy and safety of thermal ablation techniques for the treatment of primary papillary thyroid microcarcinoma: a systematic review and meta-analysis [J]. Thyroid, 2020, 30(5): 720-731.
30
葛明华, 徐栋, 杨安奎, 等. 甲状腺良性结节、微小癌及颈部转移性淋巴结热消融治疗专家共识(2018版) [J]. 中国肿瘤, 2018, 27(10): 768-773.
31
Tong M, Li S, Li Y, et al. Efficacy and safety of radiofrequency, microwave and laser ablation for treating papillary thyroid microcarcinoma: a systematic review and meta-analysis [J]. Int J Hyperthermia, 2019, 36(1): 1278-1286.
32
Lan Y, Luo Y, Zhang M, et al. Quality of life in papillary thyroid microcarcinoma patients undergoing radiofrequency ablation or surgery: a comparative study [J]. Front Endocrinol (Lausanne), 2020, 11: 249.
33
Ma B, Wei W, Xu W, et al. Surgical confirmation of incomplete treatment for primary papillary thyroid carcinoma by percutaneous thermal ablation: a retrospective case review and literature review [J]. Thyroid, 2018, 28(9): 1134-1142.
34
董文武, 张浩, 张平, 等. 甲状腺乳头状癌射频消融治疗后再手术5例临床分析 [J]. 中国实用外科杂志, 2015, 35(6): 653-655.
35
马奔, 王宇, 嵇庆海, 等. 原发性甲状腺癌热消融治疗后再手术2例分析 [J]. 中国实用外科杂志, 2016, 36(8): 875-879.
36
王宇, 马奔, 嵇庆海, 等. 甲状腺乳头状癌消融治疗后再手术策略 [J]. 医学与哲学(B), 2017, 38(7): 22-23, 27.
37
Lee CU, Kim SJ, Sung JY, et al. Needle track tumor seeding after radiofrequency ablation of a thyroid tumor [J]. Jpn J Radiol, 2014, 32(11): 661-663.
38
Brito JP, Ito Y, Miyauchi A, et al. A clinical framework to facilitate risk stratification when considering an active surveillance alternative to immediate biopsy and surgery in papillary microcarcinoma [J]. Thyroid, 2016, 26(1): 144-149.
39
Kim JH, Baek JH, Lim HK, et al. 2017 Thyroid radiofrequency ablation guideline: Korean society of thyroid radiology [J]. Korean J Radiol, 2018, 19(4): 632-655.
40
Mauri G, Hegedüs L, Bandula S, et al. European thyroid association and cardiovascular and interventional radiological society of Europe 2021 clinical practice guideline for the use of minimally invasive treatments in malignant thyroid lesions [J]. Eur Thyroid J, 2021, 10(3): 185-197.
No related articles found!
阅读次数
全文


摘要